sun pharma glp 1 Gets DCGI Approval for Semaglutide Injection | MedCognize Communications posted on the topic * Bariatric Fusion GLP Sun Pharma Wins Approval to
Description
Im joined today by two guests
to about 300,000 Da
In a study of mice by Everard A., et al
Yes, they reduce liver fat and inflammation
Semaglutide, a glucagon like peptide-1 receptor agonist with cardiovascular benefits for management of type 2 diabetes
Predictions indicate that by 2030, nearly half of the population will suffer from obesity [2]
